NORWAY COURT DECISION 'HAS NO PRACTICAL EFFECT ON PFIZER'S ABILITY TO PROTECT LIPITOR FROM THE LAUNCH OF A COMPETITOR GENERIC PRODUCT BY RANBAXY'

Pfizer Inc said that a Norwegian court decision has no practical effect on the company's ability to protect Lipitor from the launch of a competitor generic product in Norway by Ranbaxy. Yahoo Finance (http://biz.yahoo.com/prnews/060830/nyw052.html?.v=69)